21st International Congress » Parkinson's Disease: Neuroimaging And Neurophysiology

Date: Thursday, June 8, 2017

Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:15pm-2:45pm: Pathway Selective Deep Brain Stimulation Derived from Patient-Specific Models

K. Gunalan, B. Howell, R. Patriat, Y. Duchin, G. Sapiro, N. Harel, C. McIntyre (Cleveland, OH, USA)

1:15pm-2:45pm: [18F]-AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP

S. Coakeley, S.S. Cho, Y. Koshimori, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

1:15pm-2:45pm: 18F-AV-1451 PET imaging in pre-dementia Parkinson’s disease

A. Hansen, M. Damholdt, K. Knudsen, T. Fedorova, K. Østergaard, D. Brooks, P. Borghammer (Aarhus C, Denmark)

1:15pm-2:45pm: 18F-labeled FP-CIT PET Findings in a series of cirrhotic patients with parkinsonism

H.-J. Yang, S.H. Park, Y. Kim (Ulsan, Republic of Korea)

1:15pm-2:45pm: 99mTc-TRODAT-1 SPECT imaging in early and late onset Parkinson’s disease.

A. Ghabeli Juibary, V.R. Dabbagh Kakhki, P. Sasannejad, R. Sadeghi, K. Sadri, M. Sabour, H. Alizadeh (Mashhad, Islamic Republic of Iran)

1:15pm-2:45pm: A follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease and atypical parkinsonian syndrome

J. Horie, H. Fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Matsubara, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)

1:15pm-2:45pm: A neuroimaging-based model for disease progression in Parkinson’s disease

N. Shenkov, I. Klyuzhin, A. Rahmim, V. Sossi (Vancouver, BC, Canada)

1:15pm-2:45pm: A quantitative meta-analysis study of Impulse control disorders in patients with and without Parkinson’s Disease.

A. Faust- Socher, M. Criaud, A. Mihaescu, A. Lang, S. Cho, S. Houle, A. Strafella (Toronto, ON, Canada)

1:15pm-2:45pm: Aberrant resting state functional brain networks in patients with Parkinson’s disease and visual hallucinations

A. Lenka, R. Panda, L. George, S. Hegde, S. Arumugham, J. Saini, R. Bharath, P. Pal (Bangalore, India)

1:15pm-2:45pm: Abnormal DaTscan in a case of Anoxic brain injury

S. Byreddy, U. Zahid, H. Lei (Tucson, AZ, USA)

1:15pm-2:45pm: Abnormal spontaneous activity and functional connectivity in patients with Parkinson’s disease with anxiety

M. Criaud, M. Zurowski, N. Lobaugh, S. Chavez, Y. Koshimori, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

1:15pm-2:45pm: Action Observation Training Effects on Brain Structural and Functional Changes in Parkinson’s Disease Patients

E. Sarasso, F. Agosta, M. Di Meo, M. Giacobbe, M.A. Volonté, G. Comi, A. Tettamanti, R. Gatti, M. Filippi (Milan, Italy)

1:15pm-2:45pm: Alterations in Dynamic Brain Connectivity Patterns in Parkinson’s Disease

X. Dan, A. Liu, J. Wang, M. McKeown, T. Wu, P. Chan (Beijing, China)

1:15pm-2:45pm: Altered attentional brain network in Parkinson’s disease with mild cognitive impairment

J.H. Yang, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

1:15pm-2:45pm: Altered intrinsic brain functional connectivity in drug-naïve Parkinson’s disease with LRRK2 mutation

Y. Hou, C. Luo, J. Yang, R. Ou, W. Song, Y. Chen, Q. Gong, H. Shang (Chengdu, China)

1:15pm-2:45pm: Altered PDE10A Expression Detectable Early in Untreated Parkinson’s Disease Patients

G. Pagano, F. Niccolini, H. Wilson, T. Yousaf, N. Khan, D. Martino, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Altered Resting-State Functional Interhemispheric Connectivity in Parkinson’s Disease

X. Dan, S. Lin, A. Liu, J. Wang, T. Wu, P. Chan, M. McKeown (Beijing, China)

1:15pm-2:45pm: Anxiety influences the neural correlates associated with freezing of gait in Parkinson’s disease

K. Ehgoetz Martens, M. Georgiades, M. Gilat, J. Hall, J. Shine, C. Walton, S. Lewis (Camperdown, Australia)

1:15pm-2:45pm: Assessing cholinergic innervation in Parkinson’s disease using the PET imaging marker [18F]Fluoroethoxybenzovesamicol

S. vander Zee, I. Alves, A. Willemsen, P. Elsinga, T. van Laar (Groningen, Netherlands)

1:15pm-2:45pm: Assessing Nigral Functional Connectivity in Parkinson’s Disease with Resting State Functional MRI

A. Martin-Bastida, Y. Xing, S. Pietracupa, A. Roussakis, N. Lao-Kaim, W. Li, X. Li, P. Mahlknecht, S. Schwarz, T. Foltynie, D. Auer, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Assessment of substantia nigra degeneration with magnetic resonance and transcranial ultrasonography

C. Prieto, V. Suárez, C. Ordás, B. Venegas, R. Cazorla, A. Vinagre (Valdemoro, Spain)

1:15pm-2:45pm: Associations of DAT SPECT and TCS with prodromal features of Parkinson’s disease: results in PREDICT-PD participants

A. Noyce, J. Dickson, J. Bestwick, I. Isaias, M. Politis, G. Giovannoni, T. Warner, A. Lees, A. Schrag (London, United Kingdom)

1:15pm-2:45pm: Beta oscillatory changes during practice and retention of motor skills in healthy subjects and patients with PD

A. Nelson (NY, USA)

1:15pm-2:45pm: Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease

E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio (Marseille, France)

1:15pm-2:45pm: Brain structural and functional changes associated with frequent falls in Parkinson’s disease

H. Otomune, M. Mihara, H. Fujimoto, Y. Kajiyama, K. Konaka, Y. Mitani, G. Revankar, H. Mochizuki (Suita, Japan)

1:15pm-2:45pm: Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage

h. fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)

1:15pm-2:45pm: Cardiac-related pulsatility in white matter is associated with cognitive and motor performance in patients with Parkinson’s disease

Z. Shirzadi, H. Sharmarke, A. Robertson, A. Metcalfe, S. Duff-Canning, C. Marras, A. Lang, M. Masellis, B. MacIntosh (Toronto, ON, Canada)

1:15pm-2:45pm: Central pain processing in “drug-naïve” pain-free patients with Parkinson’s disease

R. De Micco, A. Russo, F. Esposito, A. Giordano, M. Fratello, G. Caiazzo, M. Cirillo, G. Tedeschi, A. Tessitore (Naples, Italy)

1:15pm-2:45pm: Clinical and Imaging and phenoconversion in the PARS prodromal cohort

K. Marek, A. Siderowf, S. Eberly, D. Oakes, M. Stern, D. Russell, J. Seibyl, D. Jennings (New Haven, CT, USA)

1:15pm-2:45pm: Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG PET imaging

F.-t. Liu, J.-j. Ge, L. Wu, Y.-j. Yang, J. Zhao, S.-s. Luo, Y.-m. Sun, J.-j. Wu, Z.-t. Ding, C.-t. Zuo, J. Wang (Shanghai, China)

1:15pm-2:45pm: Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)

1:15pm-2:45pm: Clinical Utility of Optimized Parameters for a Quantitative Analysis of 123I-ioflupane SPECT (DaTscan) Images

G. Zubal, S. Tinaz, C. Chow, H. Blumenfeld, E. Louis (New Haven, CT, USA)

1:15pm-2:45pm: Clinical utility of visualization of Nigrosome-1 in patients with Parkinson’s disease

A. Sunny, R. Naduthota, R. Botta, S. Varadharajan, J. Saini, R. Yadav, P. Pal (Bangalore, India)

1:15pm-2:45pm: Cognitive changes and cortical thinning evolution of parkinson’s disease patients: 4-year-follow up.

A. Campabadal, C. Uribe, B. Segura, H. Baggio, A. Abos, A. Garcia-Diaz, M.-J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)

1:15pm-2:45pm: Connectivity patterns in frontal cognitive regions in Parkinson’s disease

A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)

1:15pm-2:45pm: Correlation analysis between dopamine release in striatal sub-regions and motor impairment in Parkinson’s disease subjects

I. Klyuzhin, M. Sacheli, N. Vafai, E. Shahinfard, B. Lakhani, J. Neva, J. Fu, J. McKenzie, N. Neilson, K. Dinelle, L. Boyd, A. Stoessl, V. Sossi (Vancouver, BC, Canada)

1:15pm-2:45pm: Cortical phase-amplitude coupling across Parkinson’s disease phenotypes measured with magnetoencephalograph

J. Bajwa, E. Peña, L. Rosedahl, T. Mohammed, F. Almohammed, T. AlOtaibi, L. Soualmi, V. Poghosyan, S. Cooper, V. Jousmäki, M. Johnson (Riyadh, Saudi Arabia)

1:15pm-2:45pm: Decreased Fronto-Parietal connection is associated with face pareidolia in Parkinson’s disease.

Y. Kajiyama, M. Mihara, Y. Mitani, H. Otomune, H. Fujimoto, G. Revankar, K. Konaka, H. Mochizuki (Osaka, Japan)

1:15pm-2:45pm: Deep Brain Stimulation of Subthalamic Nucleus Selectively Modulates Striato-Thalamo-Cortical Circuit in Parkinson’s Disease: a Systematic Review and ALE Meta-analysis

H. Chen (Beijing, China)

1:15pm-2:45pm: Differences in cerebral perfusion between Major depression disorder and depression with Parkinson’s disease : Brain HMPAO SPECT study using SPM analysis

Y.-D. Kim, Y.-D. Kim (Incheon, Republic of Korea)

1:15pm-2:45pm: Diffusion tensor imaging changes in the corpus callosum and cognitive impairment in Parkinson’s disease

I. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J. Goldman (San Francisco, CA, USA)

1:15pm-2:45pm: Distinct pattern of striatal dopaminergic depletion in patients with parkin mutation

K.-Y. Kwon (Seoul, Republic of Korea)

1:15pm-2:45pm: Does smoking impact dopamine neuronal loss in de novo Parkinson’s disease?

Y. Lee, H.s. Yoo, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

1:15pm-2:45pm: Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

1:15pm-2:45pm: Dopamine Normalizes Putamen to Insula Activation Shift During Choice Reaction Time Task in PD

J. Kim, K. Zhang, S. YorkWilliams, M. Ua Cruadhlaoich, V. Menon, K. Poston (Palo Alto, CA, USA)

1:15pm-2:45pm: Dopamine transporter imaging predicts motor response to dopaminergic therapy for patients with advanced Parkinson’s disease: Possible role in patient selection for subthalamic deep brain stimulation.

A. Nakajima, Y. Shimo, S. Sekimoto, K. Kamagata, J. Takayuki, G. Oyama, A. Umemura, N. Hattori (Tokyo, Japan)

1:15pm-2:45pm: Early caudate involvement in Parkinson’s disease may predict future cognitive decline

R. Durcan, D. Brooks, D. Burn, N. Pavese (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients

K. Kawabata, H. Watanabe, K. Hara, E. Bagarinao, N. Yoneyama, A. Ogura, K. Imai, M. Masuda, T. Yokoi, R. Ohdake, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

1:15pm-2:45pm: EEG Markers for Emotional Inhibition in Parkinson’s Disease

N. Dissanayaka, D. Hennessy, T. Au, A. Angwin, J.H. Yang, J. O'Sullivan, D. Copland (Brisbane, Australia)

1:15pm-2:45pm: EEG Shows Subclinical Motor Preparation Deficits in Parkinson’s Disease Patients with Freezing of Gait During Locomotion

C. Fearon, J. Butler, S. Waechter, I. Killane, L. Newman, T. Munteanu, D. Birsanu, B. Magennis, R. Reilly, T. Lynch (Dublin 7, Ireland)

1:15pm-2:45pm: Evaluation of Brainstem Auditory Evoked Response and Nerve Conduction in Parkinson’s Disease

D. AGRAWAL, N. AHMED, A. CHUGHTAI (ALIGARH-202002, India)

1:15pm-2:45pm: Evaluation of SV2A expression with [18F]MNI-944 PET imaging in healthy controls (HC) and Parkinson disease (PD)

D. Russell, D. Alagille, V. Carroll, M. Thompson, J. Madonia, O. Barret, C. Constantinescu, J. Seibyl, K. Marek, G. Tamagnan (New Haven, CT, USA)

1:15pm-2:45pm: Evolution in Dopamine Transporter (DaT) Scan Utilization Patterns and its Effect on Treatment Decisions: Results of the Next 200 Scans

X.X. Yu (Cleveland, OH, USA)

1:15pm-2:45pm: Exercise alters response of reward anticipation in the ventral striatum of subjects with Parkinson’s disease

M. Sacheli, D. Murray, N. Vafai, E. Shahinfard, M. Cherkasova, K. Dinelle, N. Neilson, J. McKenzie, S. Appel-Cresswell, M. McKeown, V. Sossi, A. Stoessl (Vancouver, BC, Canada)

1:15pm-2:45pm: F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients

J. Hammes, M. Tittgemeyer, C. Eggers, A. Drzezga, T. van Eimeren (Cologne, Germany)

1:15pm-2:45pm: Functional Connectivity Differences Across Parkinson Disease Subtypes

M. Campbell, C. Gratton, J. Koller, W. Shannon, C. Lessov-Schlaggar, S. Petersen, J. Perlmutter (St. Louis, MO, USA)

1:15pm-2:45pm: Functional MAOB gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson’s disease

M. Löhle, G. Mangone, M. Wolz, B. Beuthien-Baumann, L. Oehme, J. Hoff, J. Kotzerke, H. Reichmann, J.-C. Corvol, A. Storch (Rostock, Germany)

1:15pm-2:45pm: Functional role of the cerebellum in Parkinson’s disease : a PET-Study

A. Riou, F. Le Jeune, J.-F. Houvenaghel, S. Drapier, M. Vérin, G. Robert (RENNES, France)

1:15pm-2:45pm: Gait asymmetry in people with Parkinson’s disease is linked to reduced integrity of callosal sensorimotor regions

F. Horak, C. Curtze, B. Fling (Portland, OR, USA)

1:15pm-2:45pm: Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease – on behalf of Critical Path for Parkinson’s (CPP) Consortium

D. Stephenson, J. Cedarbaum, J. Eberling, M. Facheris, D. Grosset, M. Gordon, D. Hill, S. Imam, V. Kern, G. Klein, D. Matthews, P. Muglia, A. Roach, K. Romero, D. Russell, J. Seibyl, L. Slieker, E. Somer, C. Sur, Z. Xie, K. Marek (Tucson, AZ, USA)

1:15pm-2:45pm: Globus Pallidus and Pedunculopontine Nucleus Oscillations during Executed and Imagined Gait in Patient with Parkinson’s Disease and Freezing of Gait Symptoms.

E. Opri, R. Molina, J. Shute, K. Foote, M. Okun, A. Gunduz (Gainesville, FL, USA)

1:15pm-2:45pm: Grey matter abnormalities associated with early cognitive decline in Parkinson’s disease

A. Moonen, R. Lopes, A. Leentjens, A. Duits, K. Dujardin (Maastricht, Netherlands)

1:15pm-2:45pm: High-Pass Filtered Phase MR Imaging to Detect Longitudinal Motor Associations of Iron Accumulation in Parkinson’s Disease

A. Martin-Bastida, N. Lao-Kaim, Y. Xing, C. Loane, A. Roussakis, S. Schwarz, N. Valle-Guzman, P. Mahlknecht, X. Li, G. Paul-Visse, H. Widner, M. Politis, T. Foltynie, R. Barker, D. Auer, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments

M. Miyata, S. Kakeda, J. Moriya, H. Narimatsu, T. Sato, H. Adachi, Y. Wang, Y. Korogi (Kitakyushu, Japan)

1:15pm-2:45pm: Hypertension and Parkinson’s disease

B. Giordano, G. Pagano, J. Hood, N. Ferrara, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease

I. Navalpotro-Gomez, A. Botas-Peñín, F. Molinet-Dronda, C. Gasca-Salas, M. Carmona-Abellán, H. Jiménez-Urbieta, M. Delgado-Alvarado, A. Quiroga-Varela, B. Gago, M.C. Rodríguez-Oroz (San Sebastian, Spain)

1:15pm-2:45pm: Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease

J.-H. Park, S.-K. Lee, T.-K. Lee (Bucheon-si, Republic of Korea)

1:15pm-2:45pm: Impaired sensorimotor and visual networks in drug naive Parkinson’s disease based on graph theoretical analysis

H. Chen (Beijing, China)

1:15pm-2:45pm: Improvement of memory guided saccade amplitude by the STN DBS and target eccentricity

A. YUGETA, Y. TERAO, Y. UGAWA (Tokyo, Japan)

1:15pm-2:45pm: In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)

1:15pm-2:45pm: Increased hippocampal activation in Parkinson’s disease related amnestic mild cognitive impairment

K. Perepezko, A. Gold, A. Bakker, G. Pontone, C. Speck, L. Rosenthal (Baltimore, MD, USA)

1:15pm-2:45pm: Interactions between amyloid-β and microglial activation in Parkinson’s disease

C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

1:15pm-2:45pm: Link between striatal dopamine uptake and cortical dysconnectivity in Parkinson’s disease

A. Greuel, M. Tahmasian, F. Schwartz, S. Aschenberg, F. Maier, L. Timmermann, A. Drzezga, M. Tittgemeyer, C. Eggers (Cologne, Germany)

1:15pm-2:45pm: Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson’s disease

W. Li, N. Lao-Kaim, A.-A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R. Barker, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Longitudinal Cortical Thickness Changes in GBA-Positive Relative to GBA-negative Parkinson’s Disease Patients with Hemiparkinsonism

I. Stankovic, N. Kresojevic, F. Agosta, V. Markovic, E. Sarasso, P. Valsasina, I. Petrovic, M. Filippi, V. Kostic (Belgrade, Serbia)

1:15pm-2:45pm: Longitudinal white matter microstructural change in Parkinson’s disease

C. Gallagher, V. Pozorski, J. Oh, F. Theisen, N. Adluru, A. Alexander (Madison, WI, USA)

1:15pm-2:45pm: Marked occipital hypometabolism on FDG-PET in patients with idiopathic RBD may predict Parkinson’s disease

K. Kashihara, M. Kitayama, T. Hamaguchi (Okayama, Japan)

1:15pm-2:45pm: Metabolic changes following transcranial magnetic resonance-guided focused ultrasound subthalamotomy

R. Rodriguez-Rojas, R. Martinez-Fernandez, J. Pineda-Pardo, C. Sanchez-Catasus, M. del Alamo, J. Obeso (Mostoles, Spain)

1:15pm-2:45pm: Modulation of executive motor network after neurofeedback training in Parkinson’s disease

N. Smulders, D. Mehler, L. Subramanian, D. Linden, J. Whittaker (Cardiff, United Kingdom)

1:15pm-2:45pm: Morphometric changes in Parkinson’s disease manifesting freezing of gait

S. Pietracupa, A. Suppa, N. Upadhyay, A. Zampogna, F. Di Biasio, G. Grillea, N. Modugno, G. Fabbrini, A. Berardelli, P. Pantano (Pozzilli, Italy)

1:15pm-2:45pm: Multicenter Validation of Disease- related Parkinson’s disease pattern with Resting State functional MRI

K. Schindlbeck, A. Vo, Y. Ma, S. Peng, K. Poston, H. Hurtig, N. Dahodwala, D. Eidelberg (Manhasset, NY, USA)

1:15pm-2:45pm: Neural correlates of minor hallucinations in Parkinson’s disease: A multimodal imaging study

H. Bejr-kasem, J. Pagonabarraga, S. Martinez-Horta, F. Sampedro, J. Marin-Lahoz, J. Perez-Perez, A. Horta-Barba, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

1:15pm-2:45pm: Neural Correlates Underlying Reward Processing and Decision-Making in Impulse Control Disorder in Parkinson´s Disease

I. Navalpotro-Gomez, P. Paz-Alonso, P. Boddy, M. Delgado-Alvarado, H. Jimenez-Urbieta, A. Quiroga-Varela, B. Gago, M. Carreiras, M.C. Rodriguez-Oroz (San Sebastian, Spain)

1:15pm-2:45pm: Non-motor symptom burden is associated with thalamic atrophy in Parkinson’s disease

F. Niccolini, H. Wilson, B. Giordano, K. Diamantopoulos, G. Pagano, K. Ray Chaudhuri, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients

M. Qamar, A. Sauerbier, A. Rizos, K. Chaudhuri (London, United Kingdom)

1:15pm-2:45pm: Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

M. Miyata, S. Kakeda, T. Yoneda, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

1:15pm-2:45pm: Patterns of Striatal DAT Binding Loss in a Progressing Parkinson Disease (PD) Cohort: Four year PPMI Follow-up

J. Seibyl, K. Marek (New Haven, CT, USA)

1:15pm-2:45pm: Persistent L-Dopa Responsive Hemiparkinsonism After Cryptococcoal Meningoencephalitis in an Immunocompetent Man

G. Fabiani, R. Filho, F. Germiniani, H. Teive (Curitiba, Brazil)

1:15pm-2:45pm: Post-movement beta rebound inhibits future movement

E. Rhodes, A. Kharko, W. Gaetz, S. Hall (Plymouth, United Kingdom)

1:15pm-2:45pm: Prospective Analysis of Morphological Markers of Development of Impulsive Compulsive Behaviors in De Novo Parkinson’s Disease

L. Ricciardi, C. Lambert, R. De Micco, F. Morgante, M. Edwards (London, United Kingdom)

1:15pm-2:45pm: Relationship between non-motor symptoms and dopamine transporter activity in Parkinson’ s disease

M. Iijima, H. Yoshizawa, Y. Uchiyama, K. Abe, K. Kitagawa (Tokyo, Japan)

1:15pm-2:45pm: Resting state functional connectivity in PD patients with and without Freezing of gait

K. Bharti, A. Suppa, N. Upadhyay, S. Pietracupa, G. Leodori, A. Zampogna, C. Gianni, N. Petsas, A. Berardelli, P. Pantano (Rome, Italy)

1:15pm-2:45pm: Resting state modulations of EEG low frequency bands in Parkinson’s disease.

A. Pal, N. Mehta, R. Sharma (New Delhi, India)

1:15pm-2:45pm: Serotonergic, Dopaminergic Disruptions and Related Non-Motor Features Throughout the Course of Parkinson’s Disease: A Transversal PET Study

A. Maillet, E. Météreau, E. Favre, E. Lhommée, H. Klinger, D. Le Bars, A. Castrioto, V. Sgambato-Faure, L. Tremblay, E. Broussolle, P. Krack, S. Thobois (Lyon, France)

1:15pm-2:45pm: Serotonin–to–dopamine transporter ratios in Parkinson’s dyskinesias: the longitudinal study

A.-A. Roussakis, N. Lao-Kaim, A. Martin-Bastida, N. Valle-Guzman, M. Politis, T. Foltynie, R. Barker, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

1:15pm-2:45pm: Sleep disturbance may alter white matter and resting state functional connectivities in Parkinson’s disease

S.J. Chung, Y.-H. Choi, H. Kwon, Y.-H. Park, H.J. Yun, H.S. Yoo, Y.H. Sohn, J.-M. Lee, P.H. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: SPECT imaging of striatal DAT availability in Parkinson’s: changes over time and relevance to dyskinesias

A.-A. Roussakis, D. Towey, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Speech difficulties are linked to striatal dopaminergic deficits and cognitive decline in early de novo patients with Parkinson’s disease

S. Polychronis, F. Niccolini, G. Pagano, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Striato-cortical connections in Parkinson’s and Alzheimer’s diseases: relation to cognition

I. Rektorova, L. Anderkova, M. Barton (Brno, Czech Republic)

1:15pm-2:45pm: Structural and Functional Correlates of Anxiety in Parkinson’s disease.

F. Růžička, T. Ballarini, O. Bezdíček, J. Roth, T. Sieger, J. Vymazal, E. Růžička, K. Mueller, R. Jech (Prague, Czech Republic)

1:15pm-2:45pm: Structural brain abnormalities associated with preclinical cognitive impairment in Idiopathic Parkinson’s Disease.

C. Lambert, O. Williams, L. Ricciardi, F. Morgante, T. Barrick, M. Edwards (London, United Kingdom)

1:15pm-2:45pm: Subcortical local shape volume analysis of progressive mild cognitive impairment in Parkinson`s disease

S.J. Chung, J.-H. Shin, K.h. Cho, Y. Lee, H.S. Yoo, S.J. Chung, Y.H. Sohn, J.-K. Seong, P.H. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson’s disease

M. Fabbri, S. Reimão, M. Carbalho, R. Nunes, D. Abreu, L. Guedes, R. Bouça, P. Lobo, C. Godinho, M. Coelho, N. Gonçalves, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

1:15pm-2:45pm: Swallowing difficulties and Parkinson’s disease

S. Polychronis, G. Dervenoulas, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

1:15pm-2:45pm: The brain plasticity for controlling reach-to-grasp functions of Parkinson’s disease

J. Tretriluxana, S. Tretriluxana, J. Thanakamchokchai, A. Nanbancha, A. Pisarnpong (Nakhon Pathom, Thailand)

1:15pm-2:45pm: The combination of the MIBG myocardial scintigraphy and DATSPECT contributes to the diagnosis of PD and other related disorders.

S. Tada, H. Ohtsubo, Y. Yamanishi, N. Miyaue, R. Ando, H. Yabe, N. Nishikawa, M. Nagai, M. Miyagawa, M. Nomoto (Ehime, Japan)

1:15pm-2:45pm: The effect of expectation on Parkinson’s Disease: an EEG study

E. Carlino, A. Piedimonte, G. Guerra, A. Romagnolo, E. Frisaldi, S. Vighetti, L. Lopiano (Turin, Italy)

1:15pm-2:45pm: The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson’s disease: a positron emission tomography study

S. [email protected], D. Wile, J. Fu, J. Valerio, E. Shahinfard, S. McCormick, R. Mabrouk, N. Vafai, J. McKenzie, N. Neilson, A. Perez-Soriano, J. Arena, M. Cherkasova, J. Zhang, C. Zabetian, J. Aasly, Z. Wszolek, M. McKeown, V. Sossi, A. Stoessl (Beijing, China)

1:15pm-2:45pm: The involvement of primary olfactory cortex in olfactory deficits in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q. Yang (Hershey, PA, USA)

1:15pm-2:45pm: The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy

J.-M. Kim (Seongnam, Republic of Korea)

1:15pm-2:45pm: The Putamen to Caudate Nucleus Ratio: A Simple Surrogate Marker for Dopaminergic Volume in Putamen

J.J. Lee, Y.H. Sohn (Goyang-si, Republic of Korea)

1:15pm-2:45pm: The Relative Preservation of the Dopaminergic Neuroal Loss of Patients with Parkinson’s Disease Having Dopamine-Unresponsive Resting Tremor

S. You, H.W. Kim (Daegu, Republic of Korea)

1:15pm-2:45pm: The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report

A. Tran, M. Amin, R. Burns (Phoenix, AZ, USA)

1:15pm-2:45pm: The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

1:15pm-2:45pm: U-shaped dopamine resting state connectivity response function related to working memory performance in adults with early-stage Parkinson’s disease

A. Metcalfe, S. Udow, H. Sharmarke, Z. Shirzadi, D. Long, S. Duff-Canning, C. Marras, A. Lang, B. MacIntosh, M. Masellis (Toronto, ON, Canada)

1:15pm-2:45pm: Understanding neural activation in semantic fluency in Parkinson’s disease with mild cognitive impairment

J.H. Julia, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

1:15pm-2:45pm: Utility of DaTscan Imaging in Differentiating Drug Induced Parkinsonism from IPD and Other Forms of Parkinsonism

M. Salgado, D. Panebianco, J. Muller, A. Ortega, S. (Brooklyn, NY, USA)

1:15pm-2:45pm: Utility of susceptibility weighted imaging in the objective diagnosis of idiopathic Parkinson’s Disease: Is DaTscan necessary?

R. Ellis, M. Radon, M. Bonello, M. Steiger (Liverpool, United Kingdom)

1:15pm-2:45pm: Volume analysis and localization of midbrain hyperechogenecities via TCS and MRI

A. Plate, S.-A. Ahmadi, K. Boetzel (Munich, Germany)

1:15pm-2:45pm: White Matter Microstructural Features of Motor Subtypes in De Novo, Drug Naïve Parkinson’s Disease Patient

M.-C. Wen, H. Heng, Z. Lu, Z. Xu, L.L. Chan, E.K. Tan, L. Tan (Singapore, Singapore)

1:15pm-2:45pm: Writing training enhances neural connectivity in Parkinson’s patients with micrographia

E. Nackaerts, J. Michely, E. Heremans, S. Swinnen, B. Smits-Engelsmans, W. Vandenberghe, C. Grefkes, A. Nieuwboer (Leuven, Belgium)

« View all sessions from the 21st International Congress.